Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase
AJ Brown, JJ Won, RL Graham, KH Dinnon III, AC Sims… - Antiviral research, 2019 - Elsevier
The genetically diverse Orthocoronavirinae (CoV) family is prone to cross species
transmission and disease emergence in both humans and livestock. Viruses similar to known …
transmission and disease emergence in both humans and livestock. Viruses similar to known …
[HTML][HTML] Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
…, AC Sims, SR Leist, A Schäfer, J Won, AJ Brown… - Nature …, 2020 - nature.com
Middle East respiratory syndrome coronavirus (MERS-CoV) is the causative agent of a
severe respiratory disease associated with more than 2468 human infections and over 851 …
severe respiratory disease associated with more than 2468 human infections and over 851 …
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
…, CS Hill, SA Montgomery, AJ Brown… - Science translational …, 2020 - science.org
Coronaviruses (CoVs) traffic frequently between species resulting in novel disease outbreaks,
most recently exemplified by the newly emerged SARS-CoV-2, the causative agent of …
most recently exemplified by the newly emerged SARS-CoV-2, the causative agent of …
[HTML][HTML] A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
…, BL Yount Jr, YJ Hou, LE Adams, KL Gully, AJ Brown… - Nature, 2020 - nature.com
Coronaviruses are prone to transmission to new host species, as recently demonstrated by
the spread to humans of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), …
the spread to humans of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), …
[PDF][PDF] A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice
…, W Sanders, EJ Fritch, KL Gully, T Scobey, AJ Brown… - Cell, 2020 - cell.com
The SARS-CoV-2 pandemic has caused extreme human suffering and economic harm. We
generated and characterized a new mouse-adapted SARS-CoV-2 virus that captures …
generated and characterized a new mouse-adapted SARS-CoV-2 virus that captures …
[PDF][PDF] Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the novel viral disease COVID-19. With no approved therapies, this pandemic illustrates the …
the novel viral disease COVID-19. With no approved therapies, this pandemic illustrates the …
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice
…, JJ Won, RM Meganck, FR Moreira, AJ Brown… - Science Translational …, 2022 - science.org
The coronavirus disease 2019 (COVID-19) pandemic remains uncontrolled despite the
rapid rollout of safe and effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2…
rapid rollout of safe and effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2…
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses
…, KL Gully, G De la Cruz, AJ Brown… - Science Translational …, 2024 - science.org
Despite the wide availability of several safe and effective vaccines that prevent severe
COVID-19, the persistent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-…
COVID-19, the persistent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-…
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 and multiple endemic, epidemic and bat coronavirus
…, ML Agostini, AJ Pruijssers, JD Chapell, AJ Brown… - Biorxiv, 2020 - biorxiv.org
Coronaviruses (CoVs) traffic frequently between species resulting in novel disease outbreaks,
most recently exemplified by the newly emerged SARS-CoV-2. Herein, we show that the …
most recently exemplified by the newly emerged SARS-CoV-2. Herein, we show that the …
[HTML][HTML] Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in mice.
A Schäfer, DR Martinez, JJ Won, FR Moreira, AJ Brown… - BioRxiv, 2021 - ncbi.nlm.nih.gov
The COVID-19 pandemic remains uncontrolled despite the rapid rollout of safe and effective
SARS-CoV-2 vaccines, underscoring the need to develop highly effective antivirals. In the …
SARS-CoV-2 vaccines, underscoring the need to develop highly effective antivirals. In the …
